Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000189592 | SCV000226910 | likely benign | not specified | 2017-06-12 | criteria provided, single submitter | clinical testing | |
Gene |
RCV001533534 | SCV000243235 | benign | not provided | 2021-06-07 | criteria provided, single submitter | clinical testing | |
Invitae | RCV000543561 | SCV000633895 | likely benign | Early infantile epileptic encephalopathy with suppression bursts | 2024-01-17 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002408761 | SCV002717337 | likely benign | Inborn genetic diseases | 2018-08-28 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Ce |
RCV001533534 | SCV004042367 | likely benign | not provided | 2023-09-01 | criteria provided, single submitter | clinical testing | STXBP1: PP2, BP4, BS1 |
Prevention |
RCV004552970 | SCV004773244 | likely benign | STXBP1-related disorder | 2023-08-25 | criteria provided, single submitter | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |